News Releases Home Synthetic Biology The History of Synthetic Biology Living Medicines Designing Synthetic Biotic™ Medicines Pipeline + Programs For Patients Our People Leadership Board of Directors Founders and Advisors Join Us Investors + Media Company Overview News & Events News Releases Event Calendar Presentations & Publications Stock Information Corporate Governance Financials Investor Resources Items Per Page 102550 Year None2020201920182017201620152014 May 26, 2017 Synlogic and Mirna Investor Conference Call Replay May 16, 2017 Synlogic and Mirna Investor Conference Call Information May 16, 2017 Synlogic and Mirna Therapeutics Agree to Merger March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting December 15, 2016 Synlogic Appoints COO and Head of Corporate Development November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic August 29, 2016 Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation March 23, 2016 Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors February 17, 2016 Synlogic Secures $40 Million in Series B Financing Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Next page next › Last page last » Displaying 81 - 90 of 97 Email Alerts Contact IR RSS Feeds Print Page Email Page
Items Per Page 102550 Year None2020201920182017201620152014 May 26, 2017 Synlogic and Mirna Investor Conference Call Replay May 16, 2017 Synlogic and Mirna Investor Conference Call Information May 16, 2017 Synlogic and Mirna Therapeutics Agree to Merger March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting December 15, 2016 Synlogic Appoints COO and Head of Corporate Development November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic August 29, 2016 Synlogic Proprietary Synthetic Biotic Receives FDA Orphan Drug Designation March 23, 2016 Synlogic Appoints an Industry Leader Nick Leschly to its Board of Directors February 17, 2016 Synlogic Secures $40 Million in Series B Financing Pagination First page « first Previous page ‹ previous … Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Next page next › Last page last » Displaying 81 - 90 of 97
March 23, 2017 Synlogic to Present at 2017 American College of Medical Genetics and Genomics Annual Meeting
November 10, 2016 Synlogic Secures Patent on Proprietary Synthetic Probiotic Bacteria for the Treatment of Hyperammonemia
September 12, 2016 Synlogic Expands Leadership Team to Support Rapid Advancement of the First Synthetic Biotic Towards the Clinic